{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2019:7XMX3VQVBH3IVXLAPSPHVDTMZ2","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"6e730656e9b723f52c0626724a9841015e888d1d1672b8e5f3af2a8760bda7c0","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2019-06-20T01:30:35Z","title_canon_sha256":"984bc418f8711268fa062e496ff1e48a68e5281439b2d5de42cac70e7ac19121"},"schema_version":"1.0","source":{"id":"1906.08409","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1906.08409","created_at":"2026-05-17T23:42:52Z"},{"alias_kind":"arxiv_version","alias_value":"1906.08409v1","created_at":"2026-05-17T23:42:52Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1906.08409","created_at":"2026-05-17T23:42:52Z"},{"alias_kind":"pith_short_12","alias_value":"7XMX3VQVBH3I","created_at":"2026-05-18T12:33:12Z"},{"alias_kind":"pith_short_16","alias_value":"7XMX3VQVBH3IVXLA","created_at":"2026-05-18T12:33:12Z"},{"alias_kind":"pith_short_8","alias_value":"7XMX3VQV","created_at":"2026-05-18T12:33:12Z"}],"graph_snapshots":[{"event_id":"sha256:326a3e977eeb69e042be47fb692e332916f71294b95db690eee4f6b25f5fcc85","target":"graph","created_at":"2026-05-17T23:42:52Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Four randomized placebo-controlled efficacy trials of a candidate vaccine or passively infused monoclonal antibody for prevention of HIV-1 infection are underway (HVTN 702 in South African men and women; HVTN 705 in sub-Saharan African women; HVTN 703/HPTN 081 in sub-Saharan African women; HVTN 704/HPTN 085 in U.S., Peruvian, Brazilian, and Swiss men or transgender persons who have sex with men). Several challenges are posed to the optimal design of the sequel efficacy trials, including: (1) how to account for the evolving mosaic of effective prevention interventions that may be part of the tr","authors_text":"Peter B. Gilbert","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2019-06-20T01:30:35Z","title":"Ongoing Vaccine and Monoclonal Antibody HIV Prevention Efficacy Trials and Considerations for Sequel Efficacy Trial Designs"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1906.08409","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:f7011882ad003cc871a50a235633163bcc8108f0f7211b3191ea0549cdee743b","target":"record","created_at":"2026-05-17T23:42:52Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"6e730656e9b723f52c0626724a9841015e888d1d1672b8e5f3af2a8760bda7c0","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2019-06-20T01:30:35Z","title_canon_sha256":"984bc418f8711268fa062e496ff1e48a68e5281439b2d5de42cac70e7ac19121"},"schema_version":"1.0","source":{"id":"1906.08409","kind":"arxiv","version":1}},"canonical_sha256":"fdd97dd61509f68add607c9e7a8e6cce8fe9e74c8ce7780ce3da55ee5ab24447","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"fdd97dd61509f68add607c9e7a8e6cce8fe9e74c8ce7780ce3da55ee5ab24447","first_computed_at":"2026-05-17T23:42:52.541481Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-17T23:42:52.541481Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"KuRc7R8o9whEFAXPtaa3cIsUWYu/cn6KsKVh58FtHX7mHw0Pdq/jHjYWC4HN1fQsVihrHzPqex7jgJ87GdxSBw==","signature_status":"signed_v1","signed_at":"2026-05-17T23:42:52.541968Z","signed_message":"canonical_sha256_bytes"},"source_id":"1906.08409","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:f7011882ad003cc871a50a235633163bcc8108f0f7211b3191ea0549cdee743b","sha256:326a3e977eeb69e042be47fb692e332916f71294b95db690eee4f6b25f5fcc85"],"state_sha256":"a1d8538a55b19646a4b5e18687550226884d9e0bf89500e345e4f4da82e989ea"}